FMS

Fresenius Medical Care AG & Co. KGaA

There isn't enough reported data to score FMS yet.

FMS Fundamentals

MetricStatus
Unavailable
Strong
Strong
Stable

FMS's profitability and cash flow are currently strong, and its balance sheet is stable. There isn't enough data to rate its revenue.

FMS PE Valuation

CHEAPFAIREXPENSIVE4.6x9.2x14x18x
CHEAPFAIREXPENSIVE4.6x9.2x14x18x
LevelPEPriceVs current
Cheap12x$38.09+76%
Fair12x$40.06+85%
Current13x$21.60โ€”
Expensive16x$51.64+139%

Historical ranges are pointers, not guarantees.

FMS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.

FMS Forward outlook

MetricOutlook
--
Stable
Stable
Stable
Limited
Low

Analysts expect FMS's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.

FMS Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $21.60 on Nov 12.

There is not enough scenario data to assess FMS's risk to reward.

FMS Earnings Per Share

Q2 2023: $2.26Q3 2023: $1.71Q4 2023: $1.89Q1 2024: $1.83Q2 2024: $2.01Q3 2024: $2.50Q4 2024: $2.03Q1 2025: $2.34Q2 2025: $2.49Q3 2025: $2.72Q4 2025: $3.73Q3 2026: $3.30
Q2 2023: $2.26Q3 2023: $1.71Q4 2023: $1.89Q1 2024: $1.83Q2 2024: $2.01Q3 2024: $2.50Q4 2024: $2.03Q1 2025: $2.34Q2 2025: $2.49Q3 2025: $2.72Q4 2025: $3.73Q3 2026: $3.30
QuarterTTM EPSYoY
Q3 2026$3.30+21%
Q4 2025$3.73+84%
Q3 2025$2.72+8.8%
Q2 2025$2.49+24%
Q1 2025$2.34+28%
Q4 2024$2.03+7.4%
Q3 2024$2.50+46%
Q2 2024$2.01-11%

FMS's earnings per share have fallen from their peak: $3.30 over the past year, against $5.00 in late 2020.

FMS Quarterly Revenue

Q2 2023: $5.4BQ3 2023: $5.5BQ4 2023: $5.5BQ1 2024: $5.2BQ2 2024: $5.3BQ3 2024: $5.3BQ4 2024: $5.6BQ1 2025: $5.4BQ2 2025: $5.3BQ3 2025: $5.4BQ4 2025: $5.6BQ3 2026: $16B
Q2 2023: $5.4BQ3 2023: $5.5BQ4 2023: $5.5BQ1 2024: $5.2BQ2 2024: $5.3BQ3 2024: $5.3BQ4 2024: $5.6BQ1 2025: $5.4BQ2 2025: $5.3BQ3 2025: $5.4BQ4 2025: $5.6BQ3 2026: $16B
QuarterRevenueYoY
Q3 2026$16B+195%
Q4 2025$5.6B-0.3%
Q3 2025$5.4B+2.6%
Q2 2025$5.3B+0.5%
Q1 2025$5.4B+3.3%
Q4 2024$5.6B+1.9%
Q3 2024$5.3B-3.6%
Q2 2024$5.3B-1.2%

FMS's revenue has picked up after three years of holding roughly level: $16B last quarter, up 195% from the same quarter a year ago.

FMS Free Cash Flow

Q2 2023: --Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q3 2026: --
Q2 2023: --Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q3 2026: --
QuarterFree cash flowYoY
Q3 2020$555.7M+$1B
Q2 2020$2.3B+278%

FMS Total Shares

Q2 2023: 293MQ3 2023: 293MQ4 2023: 293MQ1 2024: 293MQ2 2024: 293MQ3 2024: 293MQ4 2024: 293MQ1 2025: 293MQ2 2025: 293MQ3 2025: 292MQ4 2025: 291MQ3 2026: 269M
Q2 2023: 293MQ3 2023: 293MQ4 2023: 293MQ1 2024: 293MQ2 2024: 293MQ3 2024: 293MQ4 2024: 293MQ1 2025: 293MQ2 2025: 293MQ3 2025: 292MQ4 2025: 291MQ3 2026: 269M
PeriodChange %Net change
Quarterly-7.7%-22.4M shares
1 year-8.4%-24.6M shares
3 years-8.4%-24.6M shares
5 years-8.2%-24M shares
Available history-11%-34.6M shares

FMS has 269M diluted shares, down 8.4% from a year ago.

FMS Net Leverage

Q2 2023: 2.3xQ3 2023: 2.4xQ4 2023: 3.6xQ1 2024: 2.3xQ2 2024: 2.1xQ3 2024: 1.9xQ4 2024: 3.4xQ1 2025: 1.9xQ2 2025: 1.9xQ3 2025: 1.9xQ4 2025: 2.8xQ3 2026: 1.9x
Q2 2023: 2.3xQ3 2023: 2.4xQ4 2023: 3.6xQ1 2024: 2.3xQ2 2024: 2.1xQ3 2024: 1.9xQ4 2024: 3.4xQ1 2025: 1.9xQ2 2025: 1.9xQ3 2025: 1.9xQ4 2025: 2.8xQ3 2026: 1.9x
QuarterNet LeverageStatus
Q3 20261.9xHealthy
Q4 20252.8xModerate
Q3 20251.9xHealthy
Q2 20251.9xHealthy
Q1 20251.9xHealthy
Q4 20243.4xElevated
Q3 20241.9xHealthy
Q2 20242.1xModerate

FMS's net debt is about 1.9 years of its operating earnings (EBITDA), about the same as a year ago.

FMS Weekly Momentum

MetricValueStatus
RSI42.8Neutral
Stochastic39.7Neutral

FMS's weekly RSI is 43 (neutral) and its Stochastic is 40 (neutral).

FMS PE vs Healthcare Sector

MetricFMSSector medianRelative
PE13x26x49% below
PE %692940 pts above

FMS is trading at 13x earnings, a 49% discount to the Healthcare sector's median of 26x, though its earnings don't support one.

FMS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$22.33.1% below
20 week MA$23.16.5% below
50 week MA$23.06% below
100 week MA$24.211% below
200 week MA$22.64.3% below

FMS is in a downtrend: it's below all five of its weekly moving averages, and 4.3% below its 200-week average.

FMS Yearly ROI

YearStart priceEnd priceROI
2020$37.4$41.3+10%
2021$41.3$32.1-22%
2022$32.1$16.0-50%
2023$16.0$20.8+30%
2024$20.8$23.0+10%
2025$23.0$24.1+5%
2026 YTD$24.1$21.6-10%

FMS has finished higher in four of the last six years. It's down 10% so far in 2026.

Give your agent the market.

Get API key